No Data
Investors Can Find Comfort In Bruker's (NASDAQ:BRKR) Earnings Quality
Express News | Bruker Corp - All Ongoing Lawsuits Between Bruker and 10X Genomics to Be Withdrawn
Bruker Corporation (BRKR) Declined Amid NIH Funding and Tariff Uncertainty
AbCellera Announces The Federal Circuit Upholds Validity Of Its '408 Patent On Microfluidic Cell-Culturing Devices, Rejecting Bruker Cellular's Invalidity Challenge And Strengthening AbCellera's Position In Ongoing Patent Litigation.
There's No Escaping Bruker Corporation's (NASDAQ:BRKR) Muted Revenues
J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $60